Bipartisan Senate Bill Seeks to Strengthen Drug Supply Chain Through U.S. Manufacturing Prioritization


💊 Bipartisan Senate Bill Seeks to Strengthen Drug Supply Chain Through U.S. Manufacturing Prioritization.

A bipartisan group of senators has introduced a bill aimed at strengthening the pharmaceutical supply chain by increasing drug manufacturing in the U.S. and allied countries. The bill was drafted in response to a report that revealed over 295 medications, including critical treatments, were facing shortages in the country. The legislation would require the Department of Health and Human Services to award contracts for generic drug manufacturing to U.S.-based companies or those from the Organization for Economic Co-operation and Development. Recipients of these contracts would be required to enhance production capacity and maintain sufficient drug reserves, with the goal of ensuring the country's preparedness for future health threats and reducing reliance on foreign providers. The bill also seeks to address concerns over national security, especially related to overreliance on Communist China for vital medications.

Read more from NBC News ▶

Previous
Previous

Strike Averted, but UPS Customers May Face Higher Shipping Rates After Teamsters Deal

Next
Next

Congress Urged to Regulate Self-Driving Vehicles for Safety and Uniform Standards